《大行報告》大摩下調長實集團(01113.HK)目標價至58元 評級「增持」
摩根士丹利發表報告指,由於料長實集團(01113.HK)經常性收入預測較低,將目標價由59元下調至58元,相當每股資產淨值折讓45%,評級為「增持」。
該行將集團2023年的每股盈測下調12%,而2025年每股盈測下調5%。由於預料中國發展物業銷售較預期慢,下調今年的預售物業預測。該行指,是次的目標價亦計入了今年下半年因終止出售豪宅項目「21 BORRETT ROAD」而沒收的20億元按金,並假設項目將在未來逐步銷售,又納入最近收購Civitas Social Housing的租金貢獻和更高的淨債務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.